- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01722136
"We Walk": Impact of Exercise Dose on Health Outcomes Among Women Ages 60-75 (WW)
We Walk - Energy Expenditure and Health Outcomes in Older, Sedentary Women.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overall goal is to determine whether any energy expenditure compensation in response to 16 weeks of aerobic exercise at a higher-dose is greater compared to a lower-dose intervention in older women, and to begin to investigate underlying physiological mechanisms that influence energy expenditure changes in older women. Changes in all components of energy expenditure, as well as concentrations of plasma leptin and serum free T3, in response to the two different exercise programs (14 and 8 kcal/kg body weight weekly, 60-65% VO2max, 4 days/wk) will be compared in older, non-obese women (60-75 yrs, BMI=18-30 kg/m2).
Specific Aim 1: To determine whether differential changes in total daily energy expenditure and its components occur in older women in response to two exercise programs of different doses. State-of-the-art methods will be used (total daily energy expenditure by doubly labeled water; non-exercise activity thermogenesis using Physical Activity Monitoring System; resting metabolic rate and thermic effect of food via indirect calorimetry).
Primary Hypothesis: Due to a greater decline in NEAT, women will exhibit a smaller increase in total daily energy expenditure in response to the higher-dose, compared to the lower-dose, exercise program, despite greater increases in resting metabolic rate and thermic effect of food.
Specific Aim 2: To explore whether differential changes occur in plasma leptin and serum free triiodo-L-thyronine (free T3) concentrations in older women in response to 16-week aerobic exercise programs of two different doses.
We hypothesize that in response to the higher-dose exercise program, women will exhibit larger decreases in plasma leptin and serum free T3 concentrations, compared to the lower-dose exercise program.
We will also determine whether women exhibit greater improvements in plasma lipids, insulin sensitivity (using homeostasis model assessment, HOMA, score), blood pressure, and aerobic fitness in response to the higher-dose, compared to the lower-dose, exercise program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Columbia, South Carolina, United States, 29201
- Public Health Research Center University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 18-30
- Sedentary (exercising less than 20 minutes no more than 3 times per week)
- Non-smoking
- Weight stable (+/- 5%) over past 3 months
Exclusion Criteria:
- Self-reported cardiovascular disease
- Additional self-reported medical conditions
- Medications known to affect metabolism
- Excess caffeine use
- Self-reported contradictions according to ACSM
- Unwillingness to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low Dosage
Exercise dose of 8kcal/kg/week
|
Exercise dose of 8kcal/kg/week
|
|
Experimental: High Dosage
Exercise dose 14kcal/kg/week
|
Exercise dose of 14kcal/kg/week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline total daily energy expenditure and its components (resting metabolic rate, thermic effect of food, non-exercise activity thermogenesis)in 4 months
Time Frame: Baseline (pre-intervention); 4 months (post-intervention)
|
Baseline (pre-intervention); 4 months (post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline plasma leptin and serum free triiodo-L-thyronine (free T3) concentrations in 4 months
Time Frame: Baseline (pre-intervention); 4 month (post-intervention)
|
Baseline (pre-intervention); 4 month (post-intervention)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xuewen Wang, PhD, MEd, BM, University of South Carolina
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00016306
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Condition
-
Vanderbilt UniversityUniversity of California, IrvineCompletedCondition 1 - Educational Condition (Educational Book Group) | Condition 2 - Non-educational Condition (Non-educational Book Group) | Condition 3 - Control Condition (No-book Group)United States
-
Chinese University of Hong KongCompletedCOMBO Condition | STIGMA Condition | INTERACT Condition | CONTROL ConditionHong Kong
-
Oregon Research InstituteCompletedIntervention (Training) Condition | Control (Delayed Training) Condition
-
Marco D'AddarioCompletedInteractive Condition (HAPA-I: Group 1) | Non-interactive Condition (HAPA-NI: Group 2) | Non-communication Condition (No Comm: Group 3)Italy
-
Xiyuan Hospital of China Academy of Chinese Medical...Guangdong Provincial Hospital of Traditional Chinese Medicine; Beijing Friendship... and other collaboratorsRecruiting
-
University of ThessalyCompletedThermally Neutral Condition With Light-intensity Work | Thermally Neutral Condition With Moderate-intensity Work | Warm Condition With Light-intensity Work | Warm Condition With Moderate-intensity WorkGreece
-
Seoul National University HospitalCompletedObservation of Neuromuscular Block | Intubation Condition | Surgical ConditionKorea, Republic of
-
NanoVationCompleted
-
Max Planck Social Neuroscience LabParacelsus Medizinische Privatuniversität (PMU)Active, not recruitingControl (Delayed Training) Condition | Intervention ConditionGermany
Clinical Trials on Low Dosage
-
Norwegian University of Science and TechnologyCompleted
-
Norges idrettshøgskoleKristiania University College; ABEL TechnologiesRecruiting
-
University of JenaGerman Federal Ministry of Education and ResearchCompleted
-
Hangzhou Sciwind Biosciences Co., Ltd.CompletedWeight ManagementChina
-
Unilever R&DCompleted
-
Jun ZhangXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...Active, not recruiting
-
Ruijin HospitalCellular Biomedicine Group Ltd.Unknown
-
Seoul National University HospitalCompletedHepatocellular CarcinomaKorea, Republic of
-
Jun ZhangXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...Completed
-
Sinovac Life Sciences Co., Ltd.Completed